4.8 Article

PI3K-Akt-mTORC1-S6K1/2 Axis Controls Th17 Differentiation by Regulating Gfi1 Expression and Nuclear Translocation of RORγ

Journal

CELL REPORTS
Volume 1, Issue 4, Pages 360-373

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2012.02.007

Keywords

-

Categories

Funding

  1. CREST from Japan Science and Technology Agency
  2. Japan Society for the Promotion of Science [21790476]
  3. The Takeda Science Foundation
  4. The Mochida Memorial Foundation for Medical and Pharmaceutical Research
  5. Ministry of Health, Labour and Welfare, Japan
  6. Ministry of Education, Culture, Sports, Science and Technology, Japan [20060021]
  7. Grants-in-Aid for Scientific Research [23650593, 21390290, 23790546, 23390086, 22229004, 23130507, 24790479, 20060021, 22590439, 21790476, 24790967, 22790906] Funding Source: KAKEN

Ask authors/readers for more resources

The PI3K-Akt-mTORC1 axis contributes to the activation, survival, and proliferation of CD4(+) T cells upon stimulation through TCR and CD28. Here, we demonstrate that the suppression of this axis by deletion of p85 alpha or PI3K/mTORC1 inhibitors as well as T cell-specific deletion of raptor, an essential component of mTORC1, impairs Th17 differentiation in vitro and in vivo in a S6K1/2-dependent fashion. Inhibition of PI3K-Akt-mTORC1-S6K1 axis impairs the downregulation of Gfi1, a negative regulator of Th17 differentiation. Furthermore, we demonstrate that S6K2, a nuclear counterpart of S6K1, is induced by the PI3K-Akt-mTORC1 axis, binds ROR gamma, and carries ROR gamma to the nucleus. These results point toward a pivotal role of PI3K-Akt-mTORC1-S6K1/2 axis in Th17 differentiation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available